The ingredient was never the problem. The delivery was.
AlchemyPet is a canine supplement platform built on Swiss cold-process microencapsulation. Fragile actives are protected through the stomach and released where absorption actually happens.
Most supplements are dosed for the label, not for the patient.
A compound only works if it survives the journey to its absorption site. Conventional chews, powders, and oils expose actives to heat, oxidation, and gastric acid before uptake can occur. The gap between what is on the label and what reaches circulation is where most supplement efficacy is lost.
Thermal degradation. Extrusion and standard chew manufacturing can denature sensitive actives before they ever reach the patient.
Oxidation. Powders and oils are vulnerable to oxidative loss across shelf life and once the container is opened.
Gastric exposure. Unprotected actives meet stomach acid too early, so much of the dose is lost before the small intestine.
Illustrative absorption profile
Figures reflect delivery-system literature on encapsulated actives, not a finished-product AlchemyPet study. Product-specific PK work is on the research roadmap and detailed in the white paper.
A leaky gut is exactly where delivery matters most.
The patients most in need of functional support often have the gut least able to use it. Dysbiosis and increased intestinal permeability change the terrain an active has to survive, and they raise the cost of getting delivery wrong.
When the microbiome shifts and the epithelial barrier loosens, the gut stops behaving like a controlled absorption surface. Tight junctions widen. Endotoxins and undigested antigens cross into circulation. The local environment turns inflammatory, and motility and pH can move with it.
In that setting, an unprotected active is walking into a harder room. It faces the same heat and oxidative losses upstream, then arrives at tissue that is inflamed, dysregulated, and less forgiving. The dose on the label and the dose that lands become two very different numbers.
That is the clinical case for microencapsulation in these patients. Not a claim to repair permeability, but a way to protect fragile actives through a hostile stretch of gut and release them where uptake still works. In a healthy dog, better delivery is an advantage. In a dysbiotic one, it is often the difference between a functional dose and a wasted one.
-
Dysbiosis sets in
Microbial balance shifts, weakening the signals that maintain a healthy barrier.
-
Junctions loosen
Tight junctions widen and barrier integrity drops, the hallmark of increased permeability.
-
Translocation & inflammation
Endotoxins and antigens cross into circulation, driving a local and systemic inflammatory response.
-
Absorption destabilizes
The gut is no longer a reliable uptake surface, and unprotected actives are lost in transit.
-
Protected delivery answers here
Encapsulated actives survive the hostile stretch and release where uptake still functions.
This section describes the physiology AlchemyPet is designed to deliver into. It is a rationale for protected delivery in compromised guts, not a claim that the product treats, cures, or restores intestinal barrier function. Mechanistic detail and citations are in the white paper.
Alginate microencapsulation, cold-processed.
A seaweed-derived shell stabilizes each active, carries it past early breakdown, and is engineered to release deeper in the GI tract where uptake is highest.
Encapsulate
Each active is enclosed in an alginate microsphere derived from seaweed, forming a protective barrier around the compound.
Shield in transit
The shell buffers the active against gastric acid and oxidation, reducing premature degradation before the absorption site.
Deliver to the lower GI
The microsphere is designed to release deeper in the tract, presenting the active where uptake is most efficient.
Closed through gastric transit, releasing deeper in the GI tract.
The cold process matters as much as the shell. Actives are never exposed to the heat that degrades them in conventional manufacturing, so what is encapsulated is what reaches the patient. The result is up to 7x greater bioavailability than traditional formats. Supported by peer-reviewed delivery-system literature. Full citations in the white paper.
Release where absorption lives.
The alginate shell is built to carry actives past early breakdown and release them deeper in the GI tract, the region where the body is best positioned to take them up. It is the difference between a compound that is present and a compound that is absorbed.
The delivery science, in full.
A clinician-oriented review of the microencapsulation approach behind AlchemyPet: the mechanism, the supporting literature, formulation rationale, and an honest account of what is validated today versus what remains on the research roadmap.
- 01The bioavailability problem in canine supplementation
- 02Alginate microencapsulation and cold-process manufacturing
- 03Targeted lower-GI release and the absorption rationale
- 04Formulation logic across the five active formulas
- 05Evidence base, limitations, and the PK research roadmap
Read the full clinical review
Enter your details and we will unlock the paper for you to read and download. We built this for practitioners who want the mechanism, not the marketing.
We will occasionally share clinical updates and new evidence. Unsubscribe anytime. We never sell your information.
The hardest, most honest test of a supplement is the exam room.
AlchemyPet is carried, used, and recommended by integrative veterinarians who evaluated the delivery science before they stocked the shelf.
"AlchemyPet's bioavailability-enhanced formulas are the best first line of care I have used."
Dr. David A. Gordon, DVM · Arch Beach Veterinary, Laguna Beach
"Within two weeks she was moving more comfortably, had more energy, and was getting back to the things she loves."
Dr. Ruth Roberts, DVM, CVA · on Hiyo's recovery
Five formulas. One delivery system.
Each formula runs on the same microencapsulation science, targeted to a distinct need state you see in practice every day.
ActivExtendLongevity foundation
ImmunitySystemic defense
MobilityJoint & post-op
Clear SightOcular antioxidant
CalmingSituational & chronic
What we can stand behind, and what we are still proving.
Clinicians deserve a clear line between evidence and aspiration. Here is ours, drawn honestly.
Supported today
- +Alginate microencapsulation as a delivery mechanism, grounded in peer-reviewed literature.
- +Cold-process manufacturing that avoids the thermal degradation of conventional formats.
- +Clean-label formulation with no artificial flavors or fillers, low caloric load per serving.
- +Real integrative-vet adoption and documented field observations in practice.
On the research roadmap
- →Finished-product pharmacokinetic studies specific to AlchemyPet formulas.
- →Controlled canine trials to quantify formula-level clinical outcomes.
- →Formal absorption benchmarking against named comparator products.
- →Peer-reviewed publication of the delivery data as it matures.
Let's talk about the science
and how it fits your practice.
Whether you stock, recommend, or affiliate, the conversation starts with the delivery mechanism. Reach out and I will walk you through it directly.
Discuss the science